92 related articles for article (PubMed ID: 8752154)
1. Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells.
Seufferlein T; Rozengurt E
Cancer Res; 1996 Sep; 56(17):3895-7. PubMed ID: 8752154
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells.
Grewe M; Gansauge F; Schmid RM; Adler G; Seufferlein T
Cancer Res; 1999 Aug; 59(15):3581-7. PubMed ID: 10446965
[TBL] [Abstract][Full Text] [Related]
3. A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
Ma PC; Schaefer E; Christensen JG; Salgia R
Clin Cancer Res; 2005 Mar; 11(6):2312-9. PubMed ID: 15788682
[TBL] [Abstract][Full Text] [Related]
4. p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229.
Sugiyama H; Papst P; Gelfand EW; Terada N
J Immunol; 1996 Jul; 157(2):656-60. PubMed ID: 8752914
[TBL] [Abstract][Full Text] [Related]
5. p70s6k/p85s6k: mechanism of activation and role in mitogenesis.
Kozma SC; Thomas G
Semin Cancer Biol; 1994 Aug; 5(4):255-60. PubMed ID: 7803761
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.
Jefferies HB; Fumagalli S; Dennis PB; Reinhard C; Pearson RB; Thomas G
EMBO J; 1997 Jun; 16(12):3693-704. PubMed ID: 9218810
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin-sensitive phosphorylation of ribosomal protein S17 by p70 S6 kinase.
Patel HR; Terada N; Gelfand EW
Biochem Biophys Res Commun; 1996 Oct; 227(2):507-12. PubMed ID: 8878544
[TBL] [Abstract][Full Text] [Related]
8. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
Hidalgo M; Rowinsky EK
Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
[TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of wild type p70 S6 kinase interferes with cytokinesis.
Sugiyama H; Papst P; Fujita M; Gelfand EW; Terada N
Oncogene; 1997 Jul; 15(4):443-52. PubMed ID: 9242381
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.
Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y
Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874
[TBL] [Abstract][Full Text] [Related]
12. Insulin stimulates p70 S6 kinase in the nucleus of cells.
Kim SJ; Kahn CR
Biochem Biophys Res Commun; 1997 May; 234(3):681-5. PubMed ID: 9175775
[TBL] [Abstract][Full Text] [Related]
13. Regulation of thrombin-induced stress fibre formation in Swiss 3T3 cells by the 70-kDa S6 kinase.
Crouch MF
Biochem Biophys Res Commun; 1997 Apr; 233(1):193-9. PubMed ID: 9144421
[TBL] [Abstract][Full Text] [Related]
14. Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta.
Martin PM; Aeder SE; Chrestensen CA; Sturgill TW; Hussaini IM
Oncogene; 2007 Jan; 26(3):407-14. PubMed ID: 16832347
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis.
Le XF; Hittelman WN; Liu J; McWatters A; Li C; Mills GB; Bast RC
Oncogene; 2003 Jan; 22(4):484-97. PubMed ID: 12555062
[TBL] [Abstract][Full Text] [Related]
16. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway.
Moore SM; Rintoul RC; Walker TR; Chilvers ER; Haslett C; Sethi T
Cancer Res; 1998 Nov; 58(22):5239-47. PubMed ID: 9823338
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
18. [D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells.
Seckl MJ; Higgins T; Widmer F; Rozengurt E
Cancer Res; 1997 Jan; 57(1):51-4. PubMed ID: 8988040
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway.
Seckl MJ; Seufferlein T; Rozengurt E
Cancer Res; 1994 Dec; 54(23):6143-7. PubMed ID: 7525056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
